U.S. Food and Drug Administration
Silver Spring, Maryland
Dr. David Powers currently serves as a full-time Chemist (Research/Reviewer) in the Office of Biotechnology Products (OBP) at FDA CDER. He has over two years of experience as an FDA regulatory reviewer of chemistry, manufacturing and control (CMC) information regarding a variety of drug products that are regulated by OBP. He also has over 10 years of research experience and is highly skilled in a wide variety of analytical methods in microbiology, biochemistry and molecular biology.
Dr. Powers received a Bachelor of Science (BS) in Chemistry from the California Institute of Technology in 2005, a Master of Science (SM) from the Harvard School of Public Health in 2008 and a PhD in Biological Chemistry from UCLA in 2015. Since joining the FDA under Dr. Kurt Brorson and Dr. Cyrus Agarabi as an ORISE Fellow in April 2016, Dr. Powers has studied and developed analytics in bioprocessing, focusing on applications of mass spectrometry such as Multiple Attribute Method (MAM) and large molecule drug Critical Quality Attribute (CQA) characterization. In February 2017, Dr. Powers was converted to a full-time position and has since performed the additional role of regulatory overview for biologic submissions in OBP.
Wednesday, November 6
10:30 AM – 11:00 AM